COLOGNE, Germany – There are few countries to rival Germany for supplying gloomy gray weather in November. It's always a danger to rely too heavily on pathetic fallacy to describe the state of the biopharma industry, but to delegates arriving at the Koeln Messe Congress Centre for the 22nd annual BIO-Europe Fall meeting, the heavy clouds hanging over the cold waters of the Rhine seemed an apt metaphor for its current prospects.